Less Ads, More Data, More Tools Register for FREE

Edison

Edison's team of 50-plus analysts produces award-winning, tier one-standard equity research and investment analysis. In 2023, our international coverage includes daily in-depth scrutiny of over 225 stocks, connecting targeted investor groups across institutions, family offices, wealth managers and retail investors insight into our clients.

Edison specialises in expanding the global capital markets' understanding of our clients' investment cases. We do this through our unique combination of integrated services under the banner Complete IR which enhances our award-winning research with bespoke digital marketing services and investor relations engagement.
Date TIDM Title
16-Jan-25AAIFEnhanced dividend and new continuation vote
16-Jan-25PEBBFull year trading in line
16-Jan-25Saba Capital campaign - Your vote matters
16-Jan-250RSLTender offer successful; FY24 outperformance
15-Jan-25QEDValkor licencing revenue timing confirmed
15-Jan-25UEMDedicated focus drives long-term outperformance
15-Jan-25IMMX.USShifting the ALA treatment paradigm with CAR-T
15-Jan-25SAI.PLInfrastructure investment
14-Jan-25HUWDirect Line deal and capacity update
13-Jan-25INT.PLNext-generation AI-driven productivity
13-Jan-25CRDLContext on two recent UK deals
13-Jan-25Strong order intake drives FY25 upgrade
10-Jan-25TPTTopps Tiles - Accelerating growth through Q125
10-Jan-25USABaillie Gifford US Growth Trust - A unique high-growth strategy mer...
09-Jan-25GRGGreggs - More challenging environment in H224
09-Jan-25BRGEBlackRock Greater Europe Investment Trust - Positive prospects for...
08-Jan-25TIGTeam Internet Group - Two potential bids at 125p
03-Jan-25Mendus - Regulatory endorsement supports vididencel focus
02-Jan-25MROMelrose Industries - Fundamentals remain positive
02-Jan-25THEON.AMTheon International - Record order book and upgrade to FY25
02-Jan-25NB.USNioCorp Developments - Termination of coverage
02-Jan-25VNRX.USVolitionRx - Termination of coverage
02-Jan-25MUTMurray Income Trust - Termination of coverage
20-Dec-240FI1OPAP - Winning strategy
20-Dec-24PPETPatria Private Equity Trust - High liquidity and solid long-term tr...
20-Dec-24MNY.USMoneyHero - Emphasis on driving margin
19-Dec-240KA1Intralot - Continuing improvement in Q324
19-Dec-24PCTNPicton Property Income - Delivering on key initiatives
19-Dec-24SPA1Spatial - Wins in the utilities sector for AI-supported apps
18-Dec-24Mendus - Vididencel shines in ALISON trial (ovarian cancer)